Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Using Long-Acting Injectable Buprenorphine in Addiction Treatment

December 6, 2022
11:00 am–12:00 pm ET

This one-hour training prepares nurses and other medical professionals to use long-acting injectable buprenorphine (Sublocade) in addiction treatment.

Register now

Virtual meeting

Via Zoom

Description

This is a one-hour training that prepares nurses offering medication for opioid-use disorder to manage addiction treatment with long-acting injectable buprenorphine. Topics covered will include: the pharmacology of long-acting injectable buprenorphine; patient selection; medication storage and administration; clinical logistics; side effects; supplemental dosing; lessons learned from the field; and billing and specialty pharmacies. We will also have an open discussion to learn from each other’s experiences with using this treatment.

This training will be held via Zoom. We would prefer that you log in using a computer with a webcam so that we can all connect to each other via video. Please note that signing on with video is required to receive CEs. If you do not have access to a webcam, please let us know. 

Intended audience

Attendance is required for all OBAT nurses and MAs who work in a DPH/BSAS funded STATE OBOT program. All others working with patients on injectable buprenorphine are welcome and encouraged to attend.

Speakers

Jessica Kemp, RN, CARN Annie Potter, MSN, MPH, NP, CARN-AP

Objectives

By the end of the training, participants will have the knowledge necessary to:

Sponsored by

Boston Medical Center Grayken Center for Addiction TTA, Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

Boston Medical Center grants 1.00 hours, 1.00 of which are classifed as pharmacology hours, to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by the American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Boston University School of Social Work which is authorized through the MA state board of Social Work to provide 1.00 CE Credit Hours.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2022 Boston Medical Center. All rights reserved. Site by Root802.